Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Limón ML"'
Autor:
Carmona-Bayonas A, Jiménez-Fonseca P, Echavarria I, Sánchez Cánovas M, Aguado G, Gallego J, Custodio A, Hernández R, Viudez A, Cano JM, Martínez de Castro E, Macías I, Martín Carnicero A, Garrido M, Mangas M, Álvarez Manceñido F, Visa L, Azkarate A, Ramchandani A, Fernández Montes A, Longo F, Sánchez A, Pimentel P, Limón ML, Arias D, Cacho Lavin D, Sánchez Bayona R, Cerdá P, García Alfonso P, AGAMENON Study Group
Publikováno v:
EJSO
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Introduction: The effect of surgery for metastases in patients with esophagogastric cancer is unknown, given the lack of randomized clinical trials; likewise, the criteria for selecting eligible patients remain to be determined. Methods: This registr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::977a4d95dea0b260e3af0e2773cc0bac
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7081
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7081
Autor:
Carmona-Bayonas A, Jiménez-Fonseca P, Custodio A, Sánchez Cánovas M, Hernández R, Pericay C, Echavarria I, Lacalle A, Visa L, Rodríguez Palomo A, Mangas M, Cano JM, Buxo E, Álvarez-Manceñido F, García T, Lorenzo JE, Ferrer-Cardona M, Viudez A, Azkarate A, Ramchandani A, Arias D, Longo F, López C, Sánchez Bayona R, Limón ML, Díaz-Serrano A, Fernández Montes A, Sala P, Cerdá P, Rivera F, Gallego J, AGAMENON study group
Publikováno v:
Gastric Cancer
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Although anthracycline-based triplets are one of the most widely used schedules to treat advanced gastric cancer (AGC), the benefit of including epirubicin in these therapeutic combinations remains unknown. This study aims to evaluate both the effica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33f3d92d4953160cc76bd58c743d53ed
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7086
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7086
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lenz, Heinz Joseph, Argilés Martínez, Guillem, Yoshino, Takayuki, Lonardi, Sara, Falcone, Alfredo, Limón, María Luisa, Sobrero, Alberto, Hastedt, Claudia, Peil, Barbara, Voss, Florian, Griebsch, Ingolf, Van Cutsem, Eric, Universitat Autònoma de Barcelona
Publikováno v:
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Clin Colorectal Cancer
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Clin Colorectal Cancer
Based on European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) outputs from the LUME-Colon 1 study, we compared and discussed different statistical methods for evaluating health-related quality of li
Autor:
Lenz, Heinz-Josef, Argilés Martinez, Guillem, Yoshino, Takayuki, Lonardi, Sara, Falcone, Alfredo, Limón, María Luisa
Publikováno v:
Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
QVRS; Nintedanib; Temps de deteriorament CVRS; Nintedanib; Tiempo para el deterioro HRQoL; Nintedanib; Time to deterioration Introduction We used European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::b40dadd4e80cd52476eefd06dee56ff4
http://hdl.handle.net/11351/5867
http://hdl.handle.net/11351/5867
Autor:
Lenz, Heinz-Josef, Argilés Martinez, Guillem, Yoshino, Takayuki, Lonardi, Sara, Falcone, Alfredo, Limón, María Luisa
Publikováno v:
Scientia
Recercat. Dipósit de la Recerca de Catalunya
instname
Recercat. Dipósit de la Recerca de Catalunya
instname
QVRS; Nintedanib; Temps de deteriorament CVRS; Nintedanib; Tiempo para el deterioro HRQoL; Nintedanib; Time to deterioration Introduction We used European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::bfce9bcb23788e956ff10d96888f6478
http://hdl.handle.net/11351/5867
http://hdl.handle.net/11351/5867
Autor:
Arias-Martinez A; Doctoral Program in Pharmacy, Universidad de Granada, Barrio Verxeles n°13 2°, CP 27850, Granada, Viveiro, Spain. arantxa.91.am@gmail.com., Martínez de Castro E; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Gallego J; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain., Arrazubi V; Medical Oncology Department, Hospital Universitario de Navarra, IdiSNA, Pamplona, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC, CB16/12/00398, Madrid, Spain., Fernández Montes A; Medical Oncology Department, Complejo Hospitalario Universitario de Orense, Orense, Spain., Diez M; Medical Oncology Department, Hospital Universitario Vall d'Hebron, VHIO, Barcelona, Spain., Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Vidal-Tocino R; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca - IBSAL, Salamanca, Spain., Macias I; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Martin Richard M; Medical Oncology Department, Instituto Catalán de Oncología (ICO), L'Hospitalet de Llobregat, Barcelona, Spain., Sauri T; Medical Oncology Department, Hospital Clinic, Barcelona, Spain., Hierro C; Medical Oncology Department, Instituto Catalán de Oncología (ICO)-Badalona, Barcelona; Badalona-Applied Research Group in Oncology (B-ARGO), Badalona, Spain., Gil M; Medical Oncology Department, Hospital General Universitario de Valencia-Ciberonc CB16/12/0035, Valencia, Spain., Cerda P; Medical Oncology Department, Hospital Universitario Santa Creu y Sant Pau, Barcelona, Spain., Martínez Moreno E; Medical Oncology Department, Hospital Universitario de Fuenlabrada, Madrid, Spain., Martínez Lago N; Medical Oncology Department, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain., Mérida-García AJ; Medical Oncology Department, Complejo Asistencial de Zamora, Zamora, Spain., Gómez González L; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., García Navalón FJ; Medical Oncology Department, Hospital Universitario de Son Llatzer, Mallorca, Spain., Ruiz Martín M; Medical Oncology Department, Complejo Asistencial Universitario de Palencia, Palencia, Spain., Marín G; Medical Oncology Department, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain., López-López F; Medical Oncology Department, Hospital Universitario del Sureste, Madrid, Spain., Ruperez Blanco AB; Medical Oncology Department, Hospital Universitario de Toledo, Toledo, Spain., Fernández AF; Medical Oncology Department, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain., Alvarez-Manceñido F; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Jul; Vol. 26 (7), pp. 1674-1686. Date of Electronic Publication: 2024 Feb 15.
Autor:
Pérez-Wert P; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Paseo de La Castellana, 261, 28046, Madrid, Spain. pablopwert@gmail.com., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Paseo de La Castellana, 261, 28046, Madrid, Spain., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain., Lecumberri A; Medical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain., Cacho Lavin D; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Losantos García I; Biostatistics Unit, IdiPAZ-Hospital Universitario La Paz, Madrid, Spain., Fernández Montes A; Medical Oncology Department, Complejo Hospitalario de Orense, Orense, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain., Hernández San Gil R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Diez M; Medical Oncology Department, Hospital Universitario Val d´Hebron, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain., Vidal Tocino R; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain., Macías Declara I; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Pimentel Cáceres P; Medical Oncology Department, Hospital General Universitario Santa Lucía, Cartagena, Spain., Gil Raga M; Medical Oncology Department, Hospital General Universitario de Valencia, Valencia, Spain., Martínez Moreno E; Medical Oncology Department, Hospital Universitario de Fuenlabrada, Madrid, Spain., Sauri T; Medical Oncology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain., Martín Richard M; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain., Cerdà P; Medical Oncology Department, Hospital Universitario Santa Creu I Sant Pau, Barcelona, Spain., Gómez González L; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Mérida-García A; Medical Oncology Department, Hospital Universitario de Zamora, Zamora, Spain., Ruiz Martín M; Medical Oncology Department, Hospital Universitario Río Carrión, Palencia, Spain., Gallego J; Medical Oncology Department, Hospital General Universitario of Elche, Elche, Spain.
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2024 Jan; Vol. 27 (1), pp. 131-145. Date of Electronic Publication: 2023 Nov 15.
Autor:
Qalati SA; School of Business, Liaocheng University Liaocheng, Shandong, China., Fan M; School of Finance and Economics, Jiangsu University, Zhenjiang, China., Zhou J; School of Business, Nankai University, Tianjin, China., Sánchez Limón ML; Faculty of Commerce and Administration Victoria, Autonomous University of Tamaulipas, Ciudad Victoria, Mexico., Chen X; School of Computer Science and Technology, Shandong Institute of Business and Technology, Yantai, China.
Publikováno v:
Frontiers in psychology [Front Psychol] 2023 Jul 28; Vol. 14, pp. 1241653. Date of Electronic Publication: 2023 Jul 28 (Print Publication: 2023).
Autor:
Valcarcel S; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Avenida Roma Sn., CP 33011, Oviedo, Spain. senavg@gmail.com., Gallego J; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Diez M; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain., de Castro EM; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Arrazubi V; Medical Oncology Department, Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Montes AF; Medical Oncology Department, Complejo Hospitalario Universitario de Ourense, Orense, Spain., Macias I; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Calvo A; Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Tocino RV; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca - IBSAL, Salamanca, Spain., Lago NM; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, Coruña, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos Madrid, Madrid, Spain., Gil M; Medical Oncology Department, Hospital General Universitario de Valencia, Ciberonc CB16/12/0035, Valencia, Spain., Pimentel P; Medical Oncology Department, Hospital Santa Lucía, Cartagena, Spain., Macia-Rivas L; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Pérez CH; Medical Oncology Department, Hospital Universitario Nuestra Señora de La Candelaria, Tenerife, Spain., Mangas M; Medical Oncology Department, Hospital Galdakao-Usansolo, Galdakao-Usansolo, Spain., Carnicero AM; Medical Oncology Department, Hospital San Pedro, Logroño, Spain., Cerdà P; Medical Oncology Department, Hospital Santa Creu I Sant Pau, Barcelona, Spain., Gonzalez LG; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Navalon FG; Medical Oncology Department, Hospital Universitario Son Llatzer, Mallorca, Spain., Rambla MDM; Medical Oncology Department, Hospital Universitario Virgen de La Macarena, Seville, Spain., Richard MM; Medical Oncology Department, Catalan Institute of Oncology (ICO), L'Hospitalet, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, CP13/00126, PI17/0050 (ISCIII& FEDER), Murcia, Spain.
Publikováno v:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Jul; Vol. 149 (7), pp. 4077-4089. Date of Electronic Publication: 2022 Aug 30.